Schiller Mark C. — SEC Form 4 filings
SEC reporting owner CIK 2007659. 6 Form 4 filings on record with FilingPulse; latest filed 2026-05-11.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-07-26 to 2026-05-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 7,249 shares, $6,280 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 6,688 shares @ $0.58 ($3,879) in Kezar Life Sciences, Inc., filed 2024-07-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kezar Life Sciences, Inc. (KZR) | Chief Operating Officer | 6 | — | 2 legs · 7,249 sh · $6,280 | 13 |
Form 4 filings — Schiller Mark C.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-11 | 4 | Kezar Life Sciences, Inc. (KZR) | Code (U): 2,739 · Disposition to issuer (D): 25,000 (derivative) @ $0 · Disposition to issuer (D): 24,500 (derivative) @ $0 · Disposition to issuer (D): 12,000 (derivative) @ $0 · Disposition to issuer (D): 4,999 (derivative) @ $0 · Disposition to issuer (D): 2,499 (derivative) @ $0 · +4 more | EDGAR |
| 2025-07-03 | 4 | Kezar Life Sciences, Inc. (KZR) | Sale (S): 561 @ $4.28 | EDGAR |
| 2025-04-01 | 4 | Kezar Life Sciences, Inc. (KZR) | Grant/award (A): 4,800 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Kezar Life Sciences, Inc. (KZR) | Grant/award (A): 7,200 (derivative) @ $0 | EDGAR |
| 2025-01-13 | 4 | Kezar Life Sciences, Inc. (KZR) | Grant/award (A): 24,500 (derivative) @ $0 | EDGAR |
| 2024-07-26 | 4 | Kezar Life Sciences, Inc. (KZR) | Sale (S): 6,688 @ $0.58 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2007659 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →